Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Progression‐free survival · people with chronic lymphocytic leukaemia

It is very uncertain whether anti‐CD52 mAb maintenance therapy changes progression‐free survival compared with observation (very low certainty).

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
HR 0.55 [0.32, 0.95]
1 study · 21 participants
Very low